built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer and infectious disease. Adaptive immune responses include antibodies and T cells (CD4 and CD8), both of which can recognize damaged or infected cells.
responses or monoclonal antibodies to redirect immune cells or drugs. Harnessing Immunology to Fight Disease.
Disease. Scancell is focused on developing novel immunotherapies for the treatment of cancer and infectious disease and was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.
know-how to help in the global response to the COVID-19 pandemic. The company is leveraging its DNA vaccine expertise within oncology to produce a next-generation vaccine aimed at creating effective and long-lasting immune responses to SARS-CoV-2. Scancell initiated its COVIDITY program in collaboration with scientists at the University of Nottingham and Nottingham Trent University.
the development of cancer vaccines
to treat established cancers has been more challenging. The main goal is to increase the activity of the immune response against tumor cells, and this requires the induction of high-avidity, cytotoxic T cells. Scancell has developed two complementary vaccine platform technologies to address these issues: Moditope® and ImmunoBody®
Scancell has used
its proven ImmunoBody®
vaccine concept to design a vaccine against
SARS-CoV-2, the virus that causes COVID-19.
Scancell works actively with partners and collaborators
within both industry
its business strategy and to achieve the company’s goals.
Significant shareholders of Scancell:
Redmile Group LLC
Vulpes Life Science Fund
Shares are units of equity ownership in a corporation.
shares exist as a financial asset providing for an equal distribution of any residual profits,
if any, that are declared, in the form of dividends. Shareholders of a stock that pays no dividends do not participate in the distribution of profits.
Example of a share: A share of stock represents an ownership interest in a company. That ownership interest is proportional to the number of shares that the company has issued. Five million of those shares would be 10% and represent 10% of the company.
Scancell’s share price is 21.41GBX +0.75 (3.59%).